All Clinical Trials in Canada

A listing of 3904 clinical trials actively recruiting volunteers for paid trials and research studies in various therapeutic areas.

Home

Canada

Show Filters

Match to Clinical Trials

Access to cutting-edge treatments

Latest clinical trials

Find trials in your area

Start Matching

Filter by Age

Biologic Augment of the Medial Patellofemoral Ligament Following Primary Lateral Patellofemoral Dislocation (BioPPD)

NCT06169800

Recruiting

This study aims to determine the ability of medial patellofemoral ligament (MPFL) repair augmented with Biobrace® to decrease the re-dislocation rate after a primary patellofemoral dislocation. First-time patellofemoral dislocation is a significant problem, and the ramifications of recurrence for patients are substantial. Due to the multifactorial nature of the pathoanatomy of patellofemoral instability, it has been difficult to design trials that will show how interventions could affect the nat... Read More

Gender:

ALL

Ages:

Between 13 years and 30 years

Trial Updated:

01/31/2025

Locations: Banff Sport Medicine, Canmore, Alberta

Conditions: Patellofemoral Dislocation

Learn More ›

VOICE-Early Response to Vedolizumab and IL-23 Antagonists in Participants With Crohn's Disease: A Prospective Observational Study

NCT06249555

Recruiting

The primary aim of this study is to explore the time course of response to Vedolizumab in participants with CD as measured by the Patient-Reported Outcomes Measurement Information System (PROMIS) Pain Interference-short form (SF), as well as other PROMIS domain SFs (fatigue, anxiety, depression, sleep disturbance, physical function, and ability to participate in social roles and activities); other PRO measures will also be assessed.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

01/31/2025

Locations: GI Alliance - Sun City, Sun City, Arizona +19 locations

Conditions: Crohn's Disease

Learn More ›

The VICTORY Trial: Virtual, Innovative, Postsurgical Care To Optimize Return Home for Older People With frailtY

NCT06503198

Recruiting

Canadian hospitals continue to struggle with severe emergency department and hospital bed capacity shortages. Maximizing bed availability and minimizing emergency department and urgent-centre visits by providing patients with alternative options to care is an important part of the solution. Surgical patients with frailty are at high risk of requiring subsequent acute-hospital care. The VICTORY trial will answer an important question that will inform how to improve care for surgical patients with... Read More

Gender:

ALL

Ages:

60 years and above

Trial Updated:

01/31/2025

Locations: The Ottawa Hospital, Ottawa, Ontario

Conditions: Surgery, Frailty

Learn More ›

Managing Frailty Through Mobilization in Males and Female Inpatients with Cardiovascular Disease

NCT06810661

Recruiting

Frailty describes the overall health of a person. Inpatients with cardiovascular problems have a higher risk for frailty - or the sick are more likely to get sicker - causing longer hospital stays, hospital readmission, and death. Females are particularly vulnerable to these problems, generally displaying higher frailty levels than males. In hospital, patients spend almost all their time in bed, and this lack of movement worsens cardiovascular and musculoskeletal health, sometimes lengthening patients' hospital stay and priming them for another cardiovascular event. Prolonged sedentary time may be more detrimental on frailty among females than males. The proposed pilot project will test if an in-hospital General Medicine mobilization program reduces frailty (measure of overall health) in male and female inpatients with cardiovascular disease. A Kinesiologist will provide daily check-ins and promote daily movement (e.g., standing more, resistance bands, physical activity promotion, etc.). The investigators expect both males and females will lower their frailty levels, but given their higher frailty levels in general and because females are typically less active than males, the investigators expect the intervention's effects to be greatest among females. Sixty patients (30 females) will be recruited. Patients with a major heart problem, projected to be in-hospital for at least 3-days, and can independently provide consent. Frailty will be measured using a validated questionnaire. Participants will also be equipped with activity monitors for 24h/d continuous wear to measure amount of time spent stepping, sitting, and lying. Hospital records will be used for length of stay and readmissions. The investigators will compare the outcomes (activity and frailty) between males and females to determine if the intervention impacted each sex differently. This work will guide improved care plans to decrease frailty and improve health outcomes in both male and female patients with heart problems. Read Less

Gender:

ALL

Ages:

18 years and above

Trial Updated:

01/31/2025

Locations: Dr. Georges-L.-Dumont University Hospital CentreDr. Georges-L.-Dumont University Hospital Centre, Moncton, New Brunswick

Conditions: Cardiovascular Diseases, Frailty

Learn More ›

Tailored Axillary Surgery With or Without Axillary Lymph Node Dissection Followed by Radiotherapy in Patients With Clinically Node-positive Breast Cancer (TAXIS)

NCT03513614

Recruiting

RATIONALE: The use of tailored axillary dissection as a tailored procedure will avoid surgical overtreatment by selectively removing the lymph nodes that are affected by the cancer, thereby sparing many women the unnecessary complications of a radical surgery, providing a better quality of life while keeping the same efficacy. PURPOSE: The phase III trial is evaluating the optimal treatment for breast cancer patients in terms of surgery and radiotherapy.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

01/30/2025

Locations: Walter Reed National Military Medical Center, Bethesda, Maryland +66 locations

Walter Reed National Military Medical Center, Bethesda, Maryland

Duke University/Duke Cancer Center, Durham, North Carolina

Swedish Cancer Institute, Seattle, Washington

Sanatorio Parque Breast Cancer Center, Rosario, Santa Fe

Institute of Oncology "Angel H. Roffo, Buenos Aires, Not set

Krankenhaus Dornbirn, Dornbirn, Not set

Landeskrankenhaus Feldkirch, Feldkirch, Not set

Medical University of Innsbruck, Department of Gynecology, Innsbruck, Not set

Ordens Kinikum Linz, Barmherzige Schwestern, Linz, Not set

Universitätsklinik für Frauenheilkunde und Geburtshilfe; Landeskrankenhaus Salzburg der PMU, Salzburg, Not set

Hanusch Hospital Vienna, Vienna, Not set

Klinikum Wels-Grieskrichen GmbH, Wels, Not set

Medizinische Universität Wien - Klinik für Chirurgie, Wien, Not set

Medizinische Universität Wien - Universitätsklinik für Frauenheilkunde, Wien, Not set

CIUSSS du Centre Ouest-de-l'Île-de-Montréal, Jewish General Hospital, Montréal, Not set

Breast Centre of Clinical Hospital, Rijeka, Not set

HRUHC Sestre milosdrnice, Zagreb, Not set

Ev. Waldkrankenhaus Spandau, Berlin, Not set

KEM | Evang. Kliniken Essen-Mitte gGmbH, Essen, Not set

Niels-Stensen-Kliniken Franziskus-Hospital Harderberg, Georgsmarienhütte, Not set

Universitätsklinikum Heidelberg, Sektion Senologie, Heidelberg, Not set

ViDia Christliche Kliniken Karlsruhe, Diakonissenkrankenhaus, Karlsruhe, Not set

Onkologie Rheinsieg, Troisdorf, Not set

Helios University Hospital Wuppertal, Wuppertal, Not set

Attikon University Hospital, Chaidari, Athens

University Hospital of Heraklion, Heraklion, Crete

Alexandra General Hospital, Athens, Not set

Larissa General University Hospital, Larisa, Not set

Iaso Maternity Hospital, Marousi, Not set

Athens Medical Center Iatriko, Maroúsi, Not set

University Hospital of Patras, Patras, Not set

National Institute of Oncology, Budapest, Not set

Bacs-Kiskun Country Hospital, Kecskemet, Not set

University of Szeged, Szeged, Not set

Ospedale MultiMedica Castellanza, Castellanza, Not set

Fondazione Policlinico Universitario "Agostino Gemelli" di Roma, Rome, Not set

Gangnam Severance Hospital, Seoul, Not set

Samsung Medical Center, Seoul, Not set

Pauls Stradinš Clinical University Hospital, Rīga, Not set

National Cancer Institut, Vilnius, Not set

Kantonsspital Aarau, Aarau, Not set

Brustzentrum Basel und Netzwerk, Allschwil, Not set

Kantonsspital Baden, Baden, Not set

Universitätsspital Basel, Basel, Not set

Bethesda Spital Basel, Gynäkologie und Geburtshilfe, Basel, Not set

St. Claraspital AG, Basel, Not set

Brustzentrum Bern, Lindenhofgruppe Centerclinic, Bern, Not set

Kantonsspital Graubünden, Chur, Not set

Clinique de Grangettes, Chêne-Bougeries, Not set

Brustzentrum Thurgau, Frauenfeld, Not set

Breast center Fribourg, Fribourg, Not set

Clinique de Genolier, Genolier, Not set

HUG - Hôpitaux Universitaires de Genève, Genève, Not set

Hôpital Neuchâtelois, La Chaux-de-Fonds, Not set

Centre Hospitalier Universitaire Vaudois CHUV, Lausanne, Not set

Hirslanden Klinik St. Anna, Lucerne, Not set

Centro di Senologia della Svizzera Italiana CSSI, Lugano, Not set

Luzerner Kantonsspital - Brustzentrum, Luzern, Not set

Spital Limmattal, Schlieren, Not set

Hôpital du Valais / Hôpital de Sion, Sion, Not set

Kantonsspital St. Gallen, St. Gallen, Not set

Tumor-and Breast centre Ostschweiz, St. Gallen, Not set

Kantonsspital Winterthur, Brustzentrum, Winterthur, Not set

Spital Zollikerberg, Zollikerberg, Not set

Brust-Zentrum Zürich (Seefeld), Zürich, Not set

Stadtspital Triemli, Zürich, Not set

Universitäts Spital Zürich, Zürich, Not set

Conditions: Node-positive Breast Cancer

Learn More ›

Genomic Investigation of Unusual Responders

NCT03740503

Recruiting

Studies have shown that tumors from the same patient may respond very differently to the same therapeutic agents. This study aims to investigate the genetic basis of tumors that respond abnormally well or poorly to therapeutic agents in an effort to understand the fundamental genetic basis of this response. The present protocol seeks to retrospectively perform Exome, next-generation (DNA) sequencing and/or other molecular techniques on tumor samples to identify the genetic basis of a patient's e... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

01/30/2025

Locations: Princess Margaret Cancer Centre, Toronto, Ontario

Conditions: Cancer, Breast Cancer, Non-small Cell Lung Cancer, Colorectal Cancer, Genitourinary Cancer, Gynecological Cancer, Upper Aerodigestive Tract Cancer, Pancreatobiliary Gastrointestinal Cancer, Melanoma (Skin), Rare Cancer, Carcinoma of Unknown Primary

Learn More ›

Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma

NCT04031677

Recruiting

This is a multicenter, randomized, open label phase lll trial to assess whether preoperative chemotherapy, as an adjunct to curative-intent surgery, improves the prognosis of high risk DDLPS (dedifferentiated Liposarcoma) and LMS (Leiomyosarcoma) patients as measured by disease free survival. After confirmation of eligibility criteria, patients will be randomized to either the standard arm or experimental arm.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

01/30/2025

Locations: Mayo Clinic Hospital in Arizona, Phoenix, Arizona +148 locations

Mayo Clinic Hospital in Arizona, Phoenix, Arizona

City of Hope Comprehensive Cancer Center, Duarte, California

UC Irvine Health/Chao Family Comprehensive Ca Ctr, Orange, California

UCHealth University of Colorado Hospital, Aurora, Colorado

Smilow Cancer Hospital-Derby Care Center, Derby, Connecticut

Smilow Cancer Hospital Care Center-Fairfield, Fairfield, Connecticut

Smilow Cancer Hospital Care Center at Glastonbury, Glastonbury, Connecticut

Smilow Cancer Hospital Care Center at Greenwich, Greenwich, Connecticut

Smilow Cancer Hospital Care Center - Guiford, Guilford, Connecticut

Smilow Cancer Hospital Care Ctr at Saint Francis, Hartford, Connecticut

Yale University, New Haven, Connecticut

Yale-New Haven Hospital North Haven Medical Center, North Haven, Connecticut

Smilow Cancer Hospital Care Center at Long Ridge, Stamford, Connecticut

Smilow Cancer Hospital Care Center-Trumbull, Trumbull, Connecticut

Smilow Cancer Hospital-Waterbury Care Center, Waterbury, Connecticut

Smilow Cancer Hospital Care Center - Waterford, Waterford, Connecticut

Mayo Clinic in Florida, Jacksonville, Florida

Moffitt Cancer Center-International Plaza, Tampa, Florida

Moffitt Cancer Center - McKinley Campus, Tampa, Florida

Moffitt Cancer Center, Tampa, Florida

Emory University Hospital Midtown, Atlanta, Georgia

Northwestern University, Chicago, Illinois

University of Illinois at Chicago MBCCOP, Chicago, Illinois

Indiana Univ/Melvin and Bren Simon Cancer Center, Indianapolis, Indiana

University of Kansas Cancer Center, Kansas City, Kansas

University of Kansas Cancer Center-Overland Park, Overland Park, Kansas

University of Kansas Hospital-Westwood Cancer Ctr, Westwood, Kansas

James Graham Brown Ca Ctr at Univ of Louisville, Louisville, Kentucky

LSU Health Baton Rouge-North Clinic, Baton Rouge, Louisiana

Our Lady of The Lake Hospital, Baton Rouge, Louisiana

Our Lady of the Lake Physician Group, Baton Rouge, Louisiana

Johns Hopkins Univ/Sidney Kimmel Cancer Center, Baltimore, Maryland

Dana-Farber/Harvard Cancer Center, Boston, Massachusetts

University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan

Sanford Joe Lueken Cancer Center, Bemidji, Minnesota

Mayo Clinic, Rochester, Minnesota

Siteman Cancer Center-West County, Creve Coeur, Missouri

Washington University School of Medicine - Siteman Cancer Center, Saint Louis, Missouri

Siteman Cancer Center-South Country, Saint Louis, Missouri

Nebraska Medicine-Bellevue, Bellevue, Nebraska

Nebraska Medicine-Bellevue, Omaha, Nebraska

University of Nebraska Medical Center, Omaha, Nebraska

Dartmouth Hitchcock Med Ctr/Dartmouth Cancer Ctr, Lebanon, New Hampshire

HMH-Hackensack University Medical Center, Hackensack, New Jersey

Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey

Roswell Park Cancer Institute, Buffalo, New York

NYU Langone Hospital - Long Island, Mineola, New York

Laura and Issac Perlmutter Ca Ctr at NYU Langone, New York, New York

University of Rochester, Rochester, New York

Stony Brook University Medical Center, Stony Brook, New York

Duke University Medical Center, Durham, North Carolina

Sanford Bismarck Medical Center, Bismarck, North Dakota

Sanford Broadway Medical Center, Fargo, North Dakota

Sanford Roger Maris Cancer Center, Fargo, North Dakota

Ohio State University Comprehensive Cancer Center, Columbus, Ohio

University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma

Oregon Health and Science University, Portland, Oregon

Saint Vincent Hospital, Erie, Pennsylvania

Jefferson Hospital, Jefferson Hills, Pennsylvania

Forbes Hospital, Monroeville, Pennsylvania

Allegheny Valley Hospital, Natrona Heights, Pennsylvania

University of Pennsylvania/Abramson Cancer Center, Philadelphia, Pennsylvania

Pennsylvania Hospital, Philadelphia, Pennsylvania

Thomas Jefferson University Hospital, Philadelphia, Pennsylvania

Fox Chase Cancer Center, Philadelphia, Pennsylvania

Allegheny General Hospital, Pittsburgh, Pennsylvania

West Penn Hospital, Pittsburgh, Pennsylvania

UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania

Wexford Health and Wellness Pavilion, Wexford, Pennsylvania

Rhode Island Hospital, Providence, Rhode Island

Smilow Cancer Hospital Care Center - Westerly, Westerly, Rhode Island

Sanford Cancer Center Oncology Clinic, Sioux Falls, South Dakota

Sanford USD Medical Center - Sioux Falls, Sioux Falls, South Dakota

Vanderbilt University/Ingram Cancer Center, Nashville, Tennessee

M D Anderson Cancer Center, Houston, Texas

Huntsman Cancer Institute/University of Utah, Salt Lake City, Utah

VCU Massey Cancer Center at Hanover Medical Park, Mechanicsville, Virginia

VCU Massey Cancer Center at Stony Point, Richmond, Virginia

Virginia Commonwealth Univ/Massey Cancer Center, Richmond, Virginia

Carilion Roanoke Memorial Hospital, Roanoke, Virginia

VCU Community Memorial Health Center, South Hill, Virginia

FHCC South Lake Union, Seattle, Washington

Fred Hutchinson Cancer Center, Seattle, Washington

University of Washington Medical Center - Montlake, Seattle, Washington

Marshfield Medical Center-EC Cancer Center, Eau Claire, Wisconsin

Marshfield Medical Center, Marshfield, Wisconsin

Medical College of Wisconsin, Milwaukee, Wisconsin

Marshfield Medical Center, Minocqua, Wisconsin

Marshfield Medical Center, Rice Lake, Wisconsin

Marshfield Med Ctr-River Region at Stevens Point, Stevens Point, Wisconsin

Marshfield Medical Center, Weston, Wisconsin

Princess Alexandra Hospital - University Of Queensland, Woolloongabba, Queensland

Peter Maccallum Cancer Institute, Melbourne, Victoria

Chris O'Brian Life House - Chris O'Brien Lifehouse, Camperdown, Not set

BCCA - Vancouver Cancer Centre, Vancouver, British Columbia

London Regional Cancer Center, London, Ontario

The Ottawa Hospital - General Campus, Ottawa, Ontario

Hopital Maisonneuve Rosemont, Montréal, Quebec

The Research Institute of the McGill University Health Centre, Montréal, Quebec

Mount Sinai Hospital, Toronto, Not set

Bank Of Cyprus Oncology Centre, Stróvolos, Not set

Masaryk Memorial Cancer Institute, Brno, Not set

Herlev Hospital - University Copenhagen, Herlev, Copenhagen

Aarhus University Hospitals - Aarhus University Hospital-Skejby, Aarhus, Not set

Centre Leon Berard, Lyon, Not set

Institut du Cancer de Montpellier, Montpellier, Not set

Institut Curie- Hopital de Paris, Paris, Not set

Hopitaux Universitaires de Strasbourg - Hautepierre, Strasbourg, Not set

Institut Gustave Roussy, Villejuif, Not set

Universitaetsmedizin Goettingen - Georg-August Universitaet, Goettigen, Lower Saxony

Universitaetsklinikum Carl Gustav Carus, Dresden, Not set

UniversitaetsMedizin Mannheim, Mannheim, Not set

Centro Di Riferimento Oncologico, Aviano, Not set

IRCCS - Fondazione Piemonte Inst di Candiolo, Candiolo, Not set

IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola, Not set

Istituto Clinico Humanitas, Milano, Not set

Istituto Europeo di Oncologia, Milano, Not set

IRCCS - Istituto Nazionale dei Tumori, Milan, Not set

IRCCS - Istituto Oncologico Veneto, Padova, Not set

Policlinico Universitario Campus Bio-Medico- Oncology Center, Roma, Not set

Kyushu University Hospital, Higashi-ku, Fukuoka

Yokohama City University Hospital, Yokohama, Kanagawa

Kanagawa Cancer Center, Yokohama, Kanagawa

Tohoku University Hospital, Sendai, Miyagi

Aichi Cancer Center, Chikusa-ku, Nagoya

Nagoya University Hospital, Showa-ku, Nagoya

Niigata University Medical and Dental Hospital, Niigata City, Niigata

Okayama University Hospital, Kita-ku, Okayama

Osaka International Cancer Institute, Chuo-ku, Osaka

National Cancer Center Hospital, Chuo-ku, Tokyo

Cancer Institute Hospital of JFCR, Koto-ku, Tokyo

Saitama Medical Center, Jichi Medical University, Saitama, Not set

The Netherlands Cancer Institute-Antoni Van Leeuwenhoekziekenhuis, Amsterdam, Not set

Leiden University Medical Centre, Leiden, Not set

Radboudumc - Radboud University Medical Center Nijmegen, Nijmegen, Not set

Maria Sklodowska-Curie Memorial Cancer Centre - Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Not set

National Cancer Institute, Bratislava, Not set

Hospital De La Santa Creu I Sant Pau, Barcelona, Not set

Institut Catala d'Oncologia - ICO Badalona - Hospital Germans Trias i Pujol, Barcelona, Not set

Hospital General Universitario Gregorio Maranon, Madrid, Not set

Hospital Universitario San Carlos, Madrid, Not set

University Hospitals Birmingham - Queen Elisabeth Medical Centre, Birmingham, Not set

NHS Greater Glasgow and Clyde - Beatson West of Scotland Cancer Centre - Gartnavel General Hospital, Glasgow, Not set

Leeds Teaching Hospitals NHS Trust - St. James's University Hospital, Leeds, Not set

the Royal Marsden Hospital, London, Not set

Newcastle Hospitals - Freeman Hospital, Northern Centre For Cancer Care, Newcastle, Not set

Nottingham University Hospitals NHS Trust - City Hospital, Nottingham, Not set

Oxford University Hospitals NHS Trust - Churchill Hospital, Oxford, Not set

Clatterbridge cancer center, Wirral, Not set

Conditions: Retroperitoneal Sarcoma, Liposarcoma, Leiomyosarcoma

Learn More ›

Low-dose Naltrexone for Post-COVID Fatigue Syndrome

NCT05430152

Recruiting

This study aims to determine if low-dose naltrexone (LDN) reduces fatigue, improves related symptoms, and reduces inflammatory markers in peripheral blood in cases with Post-COVID-19 Fatigue Syndrome (PCFS) from COVID-19 (i.e. confirmed SARS-CoV-2 case). LDN refers to naltrexone given in doses of 1-4.5 mg. Overall, studies have found that LDN is safe and well-tolerated. It may help to reduce pain and inflammation and improve well-being and immune function.The trial will be conducted by the Compl... Read More

Gender:

ALL

Ages:

Between 19 years and 69 years

Trial Updated:

01/30/2025

Locations: Women's Health Research Institute, Vancouver, British Columbia

Conditions: Post-Viral Fatigue Syndrome

Learn More ›

Optimizing lymphoDepletion to Improve Outcomes In Patients Receiving Cell Therapy With Yescarta

NCT05950802

Recruiting

This is a Phase 1b study of participants with Diffuse Large B Cell Lymphoma (DLBCL). The purpose of this study is to identify an optimized lymphodenpletion (LD) regimen by evaluating standard and intermediate doses of Fludarabine (Flu) / Cyclophosphamide (Cy) with or without a fixed dose of total lymphoid irradiation (TLI) in the setting of standard of care CAR T cell therapy.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

01/30/2025

Locations: Princess Margaret Cancer Centre, Toronto, Ontario

Conditions: DLBCL - Diffuse Large B Cell Lymphoma

Learn More ›

Albumin Utilization in Adult Cardiac Surgical Patients : a Multicentre Prospective Cohort Study

NCT06395480

Recruiting

The goal of our proposed multicentre prospective cohort study is to characterize perioperative usage patterns of crystalloids and albumin, as well as key patient outcomes, in cardiac surgical patients. Results obtained from this observational study will be combined with the results of other studies to clarify the optimal role of albumin and other blood products in the perioperative management of cardiac surgical patients. This study will also address numerous other knowledge gaps in the area of... Read More

Gender:

ALL

Ages:

Between 18 years and 99 years

Trial Updated:

01/30/2025

Locations: Kingston Health Sciences Centre, Kingston, Ontario +1 locations

Conditions: Antithrombin III Levels, Albumin Levels

Learn More ›

COntralateral CorticoSTeroid Injection in Total Knee Arthroplasty

NCT06809998

Recruiting

Through a triple-blinded randomized control trial, the primary purpose of this pilot study is to assess the efficacy of administering peri-operative contralateral corticosteroid injection in patients undergoing TKA. The secondary outcome was to assess the effect of contralateral corticosteroid injection on pain and functional outcomes of patients undergoing TKA.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

01/30/2025

Locations: St. Michael's Hospital, Toronto, Ontario

Conditions: Total Knee Anthroplasty, Osteoarthritis(primary), Osteoarthritis (OA) of the Knee, Bilateral Knee Osteoarthritis

Learn More ›

Personalized Patient Derived Xenograft (pPDX) Modeling to Test Drug Response in Matching Host

NCT02732860

Recruiting

By obtaining clinical specimens from participants with triple negative breast cancer (TNBC), colorectal cancer (CRC), high grade serous ovarian cancer (HGSOC), and other select tumor types to establish and profile as freshly implanted tumors in mice, the aim of this study is to identify agents with predicted activity in the host patient while also potentially providing them with personalized cancer treatment options

Gender:

ALL

Ages:

18 years and above

Trial Updated:

01/29/2025

Locations: Princess Margaret Cancer Centre, Toronto, Ontario

Conditions: Colorectal Neoplasms, Colorectal Cancer, Breast Cancer, Breast Neoplasms, Ovarian Cancer, Ovarian Neoplasm

Learn More ›